We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NIO icon
376
NIO
NIO
$11.5B
$1.7K ﹤0.01%
175
– –
SPLK
377
DELISTED
Splunk Inc
SPLK
$1.38K ﹤0.01%
+13
New +$1.24K
AZIO
378
Azio AI Holdings
AZIO
$22.6M
$1.36K ﹤0.01%
65
– –
ARKK icon
379
ARK Innovation ETF
ARKK
$6.01B
$1.32K ﹤0.01%
30
– –
STZ icon
380
Constellation Brands
STZ
$22.6B
$1.23K ﹤0.01%
5
– –
LAZR
381
DELISTED
Luminar Technologies
LAZR
$688 ﹤0.01%
7
– –
NFLX icon
382
Netflix
NFLX
$307B
$669 ﹤0.01%
20
– –
DDD icon
383
3D Systems Corp
DDD
$588M
$497 ﹤0.01%
50
– –
NBIX icon
384
Neurocrine Biosciences
NBIX
$16.2B
$472 ﹤0.01%
5
– –
IP icon
385
International Paper
IP
$21.5B
$319 ﹤0.01%
10
– –
SAM icon
386
Boston Beer
SAM
$1.88B
$316 ﹤0.01%
1
– –
STIM icon
387
Neuronetics
STIM
$157M
$215 ﹤0.01%
100
– –
TD icon
388
Toronto Dominion Bank
TD
$200B
$125 ﹤0.01%
2
– –
INO icon
389
Inovio Pharmaceuticals
INO
$69.6M
$101 ﹤0.01%
19
– –
PSX icon
390
Phillips 66
PSX
$82.4B
$96 ﹤0.01%
1
– –
TRIB
391
Trinity Biotech
TRIB
$7.86M
$96 ﹤0.01%
1
– –
VT icon
392
Vanguard Total World Stock ETF
VT
$79.1B
$92 ﹤0.01%
1
– –
FSFG
393
DELISTED
First Savings Financial Group
FSFG
$40 ﹤0.01%
3
– –
WKHS icon
394
Workhorse Group
WKHS
$35.2M
– –
0
– –
CGC
395
Canopy Growth
CGC
$394M
$8 ﹤0.01%
2
– –
TLRY icon
396
Tilray
TLRY
$605M
– –
0
– –
BHF icon
397
Brighthouse Financial
BHF
$3.57B
– –
-23
Closed -$1.01K
FXZ icon
398
First Trust Materials AlphaDEX Fund
FXZ
$388M
– –
-3,315
Closed -$217K
12 13 14 15
16

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.